Article Details
Retrieved on: 2018-03-13 08:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Torrent Pharma's track record of successful turnaround of the acquired Elder business and debt reduction post the acquisition in FY14, provides comfort,” <b>Spark Capital</b> said in a research note last month. Emails sent on Friday to Torrent Pharma and JM Financial did not elicit any response. JP Morgan ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here